C Blais1,2, L Rochette1. 1. Institut national de santé publique du Québec, Québec, Quebec, Canada. 2. Faculté de pharmacie, Université Laval, Québec, Quebec, Canada.
Abstract
INTRODUCTION: Of all cardiovascular causes of mortality, coronary heart disease (CHD) remains the leading cause of death. Our objectives were to establish trends in the prevalence and incidence of CHD in the province of Quebec, and to determine the proportion of CHD mortality that had no previous CHD diagnosis. METHODS: Trends in prevalence, incidence and mortality were examined with a population-based study using the Quebec Integrated Chronic Disease Surveillance System, which links several health administrative databases. Data are presented using two case definitions for Quebecers aged 20 years and over: 1) a validated definition, and 2) CHD causes of death codes added to estimate the proportion of deaths that occurred without any previous CHD diagnosis as a proxy for sudden cardiac death (SCD). RESULTS: In 2012/2013, the crude prevalence of CHD was 9.4% with the first definition (593 000 people). Between 2000/2001 and 2012/2013, the age-standardized prevalence increased by 14%, although it has been decreasing slightly since 2009/2010. Age-standardized incidence and mortality rates decreased by 46% and 26% respectively, and represented a crude rate of 6.9 per 1000 and 5.2% in 2012/2013. The proportion identified only by CHD mortality, our SCD proxy, was only significant for the incident cases (0.38 per 1000 in 2009/2010) and declined over the study period. CONCLUSION: The prevalence of CHD has tended to decrease in recent years, and incidence and mortality have been declining in Quebec. Most CHD mortality occurs in previously diagnosed patients and only a small proportion of incident cases were not previously identified.
INTRODUCTION: Of all cardiovascular causes of mortality, coronary heart disease (CHD) remains the leading cause of death. Our objectives were to establish trends in the prevalence and incidence of CHD in the province of Quebec, and to determine the proportion of CHD mortality that had no previous CHD diagnosis. METHODS: Trends in prevalence, incidence and mortality were examined with a population-based study using the Quebec Integrated Chronic Disease Surveillance System, which links several health administrative databases. Data are presented using two case definitions for Quebecers aged 20 years and over: 1) a validated definition, and 2) CHD causes of death codes added to estimate the proportion of deaths that occurred without any previous CHD diagnosis as a proxy for sudden cardiac death (SCD). RESULTS: In 2012/2013, the crude prevalence of CHD was 9.4% with the first definition (593 000 people). Between 2000/2001 and 2012/2013, the age-standardized prevalence increased by 14%, although it has been decreasing slightly since 2009/2010. Age-standardized incidence and mortality rates decreased by 46% and 26% respectively, and represented a crude rate of 6.9 per 1000 and 5.2% in 2012/2013. The proportion identified only by CHD mortality, our SCD proxy, was only significant for the incident cases (0.38 per 1000 in 2009/2010) and declined over the study period. CONCLUSION: The prevalence of CHD has tended to decrease in recent years, and incidence and mortality have been declining in Quebec. Most CHD mortality occurs in previously diagnosed patients and only a small proportion of incident cases were not previously identified.
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: Claudia Blais; Sulan Dai; Chris Waters; Cynthia Robitaille; Mark Smith; Lawrence W Svenson; Kim Reimer; Jill Casey; Rolf Puchtinger; Helen Johansen; Yana Gurevich; Lisa M Lix; Hude Quan; Karen Tu Journal: Can J Cardiol Date: 2013-12-20 Impact factor: 5.223
Authors: C Blais; S Jean; C Sirois; L Rochette; C Plante; I Larocque; M Doucet; G Ruel; M Simard; P Gamache; D Hamel; D St-Laurent; V Emond Journal: Chronic Dis Inj Can Date: 2014-11
Authors: Melissa H Kong; Gregg C Fonarow; Eric D Peterson; Anne B Curtis; Adrian F Hernandez; Gillian D Sanders; Kevin L Thomas; David L Hayes; Sana M Al-Khatib Journal: J Am Coll Cardiol Date: 2011-02-15 Impact factor: 24.094
Authors: V Salomaa; M Ketonen; H Koukkunen; P Immonen-Räihä; T Jerkkola; P Kärjä-Koskenkari; M Mähönen; M Niemelä; K Kuulasmaa; P Palomäki; J Mustonen; M Arstila; T Vuorenmaa; A Lehtonen; S Lehto; H Miettinen; J Torppa; J Tuomilehto; Y A Kesäniemi; K Pyörälä Journal: Circulation Date: 2003-07-28 Impact factor: 29.690
Authors: Hanyu Ni; Sean Coady; Wayne Rosamond; Aaron R Folsom; Lloyd Chambless; Stuart D Russell; Paul D Sorlie Journal: Am Heart J Date: 2008-10-26 Impact factor: 4.749
Authors: Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell Journal: N Engl J Med Date: 2007-06-07 Impact factor: 91.245
Authors: Cynthia Robitaille; Christina Bancej; Sulan Dai; Karen Tu; Drona Rasali; Claudia Blais; Céline Plante; Mark Smith; Lawrence W Svenson; Kim Reimer; Jill Casey; Rolf Puchtinger; Helen Johansen; Yana Gurevich; Chris Waters; Lisa M Lix; Hude Quan Journal: BMC Cardiovasc Disord Date: 2013-10-20 Impact factor: 2.298